From CancerCare

Caring for the caregiver

December 19, 2011

The person who provides care and support at home is an integral part of a patient's care. Nurses need to check on them, too.
 

The importance of cultural competence

Helen H. Miller, LCSW October 19, 2011

A bevy of tools are available to help oncology nurses improve their understanding of patients' cultures.
 

Cancer and the workplace

Helen H. Miller, LCSW August 01, 2011

Many cancer patients continue to work during treatment. Available resources range from advice on talking with their supervisors to federal laws that protect their rights.
 

Facing the challenges of cancer treatment as a young adult

Helen H. Miller, LCSW May 19, 2011

Young adults often have to manage their cancer care on their own. They need helpful resources that address their particular issues.
 

The financial burden of cancer care

Helen H. Miller, LCSW March 17, 2011

Cancer treatment incurs more than direct health care costs. These organizations can help your patients with the extra expenses of cancer treatment.
 

Caregivers: A critical link in successful care management

Helen H. Miller, LCSW, ASW January 19, 2011

Caregivers are an essential part of patient care. Attentiveness to their concerns is an important part of caring for the patient with cancer.
 

Collaborative care plans for posttreatment cancer survivors

Helen H. Miller, LCSW, ASW October 01, 2010

Collaboration between the patient and health care provider about a posttreatment care plan can improve the patient's quality of life.
 

Lightening the burden of costly co-payments for cancer treatment

Helen H. Miller, LCSW August 01, 2010

When making the copayments on expensive cancer therapies becomes a struggle for patients, a referral to CancerCare can help to alleviate the burden.
 

Support is just a telephone call away

Helen H. Miller, LCSW July 15, 2010

When cancer patients need care and information that their primary health care team cannot provide, individualized counseling and support can often make all the difference.
 

Talking to your patients about melanoma screening, prevention, and support

Rosalie Canosa, LCSW-R, MPA May 05, 2010

CancerCare has partnered with the Melanoma Research Foundation to launch The Melanoma Helpline, which helps people diagnosed with melanoma to access resources and support.
 

Two vital resources for melanoma management


Two myCME Webcasts, Management of Metastatic Melanoma and Management of Early Melanoma and Atypical Spitz Tumors, provide health care professionals with current and relevant research, treatment options, clinical data, guidance, and resources to optimize melanoma detection, management, patient care, and outcomes. Each Webcast offers 1.0 AMA PRA Category 1 CreditTM.

Visit Reflections for first-hand stories on the power of the patient to impact caregivers in oncology nursing.

Let us know what you are looking for in a new oncology nursing journal:

Click here to take our survey

ONA Newsletters
Sign up today for one of our free newsletters:
  • Issue Preview
  • Latest CE
  • Reflections
  • Editor's choice
  • New on the Web
FEBRUARY 3 - 4
2012 Highlights of ASH in North America
New York, New York
2012 Highlights of ASH in North America
San Francisco, California
MARCH 3 - 4
2012 Highlights of ASH in Asia
Singapore, Singapore
MAY 3 - 6
37th Annual ONS Congress
New Orleans, Louisiana
 Subscribe to the RSS for this page  [view all our RSS feeds here]

Web Exclusives

Psychosocial approach useful in managing cancer pain

February 03, 2012

Psychosocial interventions, including skills instruction and education, can help reduce pain in persons with cancer, confirm the results of a recent meta-analysis.
 

Experimental agent slows progression of colorectal cancer

February 02, 2012

The investigational drug regorafenib conferred a statistically significant survival benefit in patients with metastatic colorectal cancer in whom no standard therapy was effective.
 

In HER2 breast cancer, lapatinib works better with trastuzumab than without

February 01, 2012

Lapatinib is not as effective as trastuzumab against (HER2)-positive breast cancer, but combining the two nearly doubles the effectiveness seen with either one alone.
 

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions